AB 1103: Controlled substances: research.

this bill aims to amend certain laws related to controlled substances. it would require the research advisory panel to review research projects that involve the administration of schedule i or ii controlled substances. the panel would be authorized to expedite the review of projects that meet certain criteria, including federal approvals and independent peer review. the bill would also allow the chairperson to deputize panel members to review and approve projects without a full panel vote. additionally, the bill would extend the authorization for closed sessions until january 1, 2028, and exempt panel members from the bagley-keene open meeting act during this period. the bill also includes legislative findings to support the limitation on access to meetings and writings of public officials and agencies.